E-Home Household Services Holdings Limited's subsidiary Zhongrun Pharmaceutical and New Zealand's NBL Pharmaceuticals Sign Cooperation Agreement to Expand International Markets

Core Viewpoint - E-Home Household Services Holdings Limited is set to merge with New Zealand's NBL Pharmaceuticals, aiming to enhance its competitiveness and expand its overseas market presence through a signed cooperation agreement [1][3]. Company Overview - E-Home Household Services Holdings Limited, established in 2014, is a Nasdaq-listed company based in Fuzhou, China, providing integrated household services [4]. - The company offers services including installation and maintenance of home appliances, housekeeping, elderly care, and public cleaning [4][5]. Merger Details - The merger between E-Home's subsidiary, Zhongrun (Fujian) Pharmaceutical Co., Ltd., and NBL Pharmaceuticals is planned for December 2024, following extensive due diligence conducted by both parties [1]. - The cooperation agreement aims to create a comprehensive healthcare drug portfolio, leveraging both Chinese and international resources for better market positioning [3]. Production Capabilities of NBL Pharmaceuticals - NBL Pharmaceuticals operates in Auckland, New Zealand, with advanced automated production lines and a factory area exceeding 5,000 square meters, including over 2,200 square meters of purification workshop [2]. - The production facilities comply with international GMP standards, focusing on health care products such as fish oil and vitamins [2]. Strategic Importance - The cooperation agreement is viewed as a significant step in E-Home's internationalization strategy, aimed at establishing global partnerships and enhancing brand influence [3]. - The merger is expected to provide numerous business opportunities and deepen exchanges with overseas markets [3].